Table 1.

Baseline characteristics of study cohort of patients aged 41–55 years matched 1:2 by age, sex, and index date.

Non-gout, n = 8352Gout, n = 4176P*
Follow-up duration, cancer, yrs10.1 ± 210.1 ± 2.30.49
Follow-up duration, mortality, yrs10.5 ± 1.610.5 ± 1.70.23
Age, yrs48.8 ± 3.848.8 ± 3.8> 0.99
Sex, female2488 (29.8)1244 (29.8)> 0.99
Incomea< 0.0001
    Group 1 (1–3)1601 (19.2)633 (15.1)
    Group 2 (4–7)2629 (31.5)1251 (30.0)
    Group 3 (8–10)4122 (49.4)2292 (54.9)
Urban0.003
    Seoul1366 (16.4)677 (16.2)
    Metropolitan city2607 (31.2)1186 (28.4)
    Other4379 (52.4)2313 (55.4)
Smoking0.03
    None4665 (55.9)2378 (56.9)
    Ex-smoker980 (11.7)542 (13.0)
    Current2306 (27.6)1067 (25.6)
    Unknown401 (4.8)189 (4.5)
Alcohol, no. drinks< 0.0001
    None3787 (45.3)1814 (43.4)
    2–3/month1545 (18.5)735 (17.6)
    1–2/week1931 (23.1)955 (22.9)
    3–4/week673 (8.1)434 (10.4)
    Daily283 (3.4)177 (4.2)
    Unknown133 (1.6)61 (1.5)
Comorbidities
    Diabetes mellitus654 (7.8)549 (13.1)< 0.0001
    Hypertension1162 (13.9)1170 (28.0)< 0.0001
    Kidney disease83 (1.0)142 (3.4)< 0.0001
    COPD58 (0.7)60 (1.4)< 0.0001
    H. pylori–related diseasesb1924 (23)1528 (36.6)< 0.0001
Measurements
    BMI24.0 ± 2.724.8 ± 2.73< 0.0001
    SBP, mmHg124.8 ± 15.7126.7 ± 16.8< 0.0001
    DBP, mmHg79.2 ± 10.780.5 ± 11.5< 0.0001
    Fasting glucose, mg/dL96.4 ± 2396.4 ± 21.60.88
    Total cholesterol, mg/dL198.1 ± 35.3200.8 ± 380.001
    Hemoglobin, g/dL14.3 ± 1.514.3 ± 1.50.18
  • Continuous variables are presented as the mean ± SD or median (IQR). Categorical variables are presented as n (%).

  • * Chi-square test was conducted for categorical variables and t test for continuous variables.

  • a Income divided into 10 grades and grouped by 3 categories, where group 3 is the highest grade.

  • b Helicobacter pylori·-related diseases, including peptic ulcers. COPD: chronic obstructive pulmonary disease; DBP: diastolic blood pressure; SBP: systolic blood pressure.